Prof. Jalid Sehouli, Berlin, to new study results about ovarian cancer from ESGO-Kongress 2017
11. November 2017
Last year’s congress of the European Society of Gynaecological Oncology has brought new results for curative treatment of advanced ovarian cancer – the most common cause of ascites. Patients can soon benefit by a new targeted therapy. Furthermore there has also been a transition to more lymph node obtaining surgeries.
Besides that Prof. Sehouli presents the interesting results of a medical survey about therapy goals and preferences of patients with ovarian cancer (German):